Skip to main content

Amyris, Inc. (AMRS)

NASDAQ: AMRS · IEX Real-Time Price · USD
13.25
+0.03 (0.23%)
After-hours:Oct 15, 2021 7:38 PM EDT
13.22
-0.23 (-1.71%)
At close: Oct 15, 4:00 PM
Market Cap4.01B
Revenue (ttm)343.18M
Net Income (ttm)-466.37M
Shares Out320.09M
EPS (ttm)-1.81
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,135,159
Open13.70
Previous Close13.45
Day's Range13.21 - 13.73
52-Week Range1.88 - 23.42
Beta1.24
AnalystsStrong Buy
Price Target22.83 (+72.7%)
Est. Earnings DateNov 4, 2021

About AMRS

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Ins...

IndustryChemicals
IPO DateSep 28, 2010
CEOJohn Melo
Employees595
Stock ExchangeNASDAQ
Ticker SymbolAMRS
Full Company Profile

Financial Performance

In 2020, Amyris's revenue was $173.14 million, an increase of 13.49% compared to the previous year's $152.56 million. Losses were -$331.04 million, 36.4% more than in 2019.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for Amyris stock is "Strong Buy." The 12-month stock price forecast is 22.83, which is an increase of 72.69% from the latest price.

Price Target
$22.83
(72.69% upside)
Analyst Consensus: Strong Buy

News

7 Sin Stocks to Buy as the World Goes to Hell in a Handbasket

Sin stocks are considered defensive and tend to remain more stable under tough economic conditions. Here are the top ones to watch in 2021.

Other symbols:MGMMOPENNSMGSWBIUBS
1 week ago - InvestorPlace

Amyris Hosts Successful Fourth Webinar In Its Virtual Investor Mini-Series

EMERYVILLE, Calif., Oct. 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a t...

2 weeks ago - PRNewsWire

Amyris To Host Fourth Webinar In Its Virtual Investor Mini-Series

EMERYVILLE, Calif., Sept. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in the Clean Health, Beauty and Wellness markets, today announced that it will h...

3 weeks ago - PRNewsWire

Amyris to Present at Two September Investor Conferences

EMERYVILLE, Calif., Sept. 8, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier...

1 month ago - PRNewsWire

Amyris Closes Acquisition Of Beauty Labs Combining Synthetic Biology Leadership With Digital Innovation

EMERYVILLE, Calif., Sept. 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier...

1 month ago - PRNewsWire

Carvana Co Ranked Among Today's Top Shorts On The Final Trading Day In August

As we are in the final trading day of August, the Dow Jones is up 1.3%, the S&P 500 is up 3%, and the Nasdaq is up 4%, month-to-date. Make the most of this market with today's Top Shorts from Q.ai's art...

Other symbols:CVNABLNKLTHMPLUG
1 month ago - Forbes

American Airlines Group Inc Ranked Among Today's Top Shorts As Investors Await The Fed's Talk On Tapering

The Dow Jones gained 65 points, while the S&P 500 and Nasdaq each gained 0.2%. Find opportunities in this market with the best short plays from Q.ai's deep learning algorithms.

Other symbols:AALARVNCVNA
1 month ago - Forbes

Amyris Inc Among Today's Top Shorts As Investors Await More On Fed's Tapering Plans

The Dow Jones rose about 42 points or 0.1%, the S&P 500 lost 0.08%, and the Nasdaq fell 0.04%. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

1 month ago - Forbes

Amyris And Jonathan Van Ness Launch JVN Hair A Transformation In Clean Hair Products

EMERYVILLE, Calif., Aug. 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier...

1 month ago - PRNewsWire

Amyris Closes Acquisitions Of OLIKA Inc. And MG Empower

EMERYVILLE, Calif., Aug. 24, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier...

1 month ago - PRNewsWire

Amyris Among Today's Top Shorts Amid News That The Central Bank Could Taper Its Bond Purchasing Program

The Dow Jones is up 150 points, or nearly 0.5%, and the S&P 500 and Nasdaq are each up about 0.5%. Make the most of this market with today's best short plays from Q.ai's deep learning algorithms.

1 month ago - Forbes

Amyris And Rosie Huntington-Whiteley's Rose Inc. Brand Launches Its First Collection Of Beauty Products

EMERYVILLE, Calif., Aug. 23, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer bran...

1 month ago - PRNewsWire

Why Amyris Stock Jumped Today

The company announced promising results from a study of its experimental intranasal COVID-19 vaccine.

1 month ago - The Motley Fool

Amyris Achieves Promising In-Vivo Results For Intranasal Delivery Of RNA/NLC Vaccine

EMERYVILLE, Calif., Aug. 20, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a ...

1 month ago - PRNewsWire

Amyris Inc Among Today's Top Shorts As Major Indices Fall Following The Fed's Meeting Minutes

The Dow Jones dropped around 145 points or 0.4%, the S&P 500 fell 0.4%, and the Nasdaq dipped 0.5%. Find opportunities in today's market with today's best short plays from Q.ai's artificial intelligence.

1 month ago - Forbes

Amyris Launches Terasana Clinical Clean Skincare Brand

EMERYVILLE, Calif., Aug. 19, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier...

1 month ago - PRNewsWire

AI Identifies Amyris Inc Among Today's Top Shorts As Investors Anticipate The Fed's Next Stimulus Moves

The 10-year Treasury yield inched up to around 1.27%, the Dow fell 120 points, the S&P 500 dipped about 0.2%, and the Nasdaq stayed nearly flat. If you're looking for a way to play this market, the deep...

1 month ago - Forbes

Amyris Launches Next Virtual Investor Mini-Series

EMERYVILLE, Calif., Aug. 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a ...

2 months ago - PRNewsWire

Arvinas Inc Ranked Among Today's Top Shorts

Markets were slightly lower this morning after the Dow Jones touched all-time highs at the open. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

Other symbols:ARVNCVNALTHMTUP
2 months ago - Forbes

Zymergen's Implosion Makes Amyris a Screaming Buy

The flashy synthetic-biology start-up ran into a wall that Amyris has already learned how to climb over.

Other symbols:ZY
2 months ago - The Motley Fool

Amyris Inc Ranked Among Today's Top Shorts

To close out August's opening week, the Dow Jones rose 101 points, or 0.3%, the S&P 500 was flat, and the Nasdaq fell 0.4%. Find opportunities in today's market with the best short plays from Q.ai's dee...

Other symbols:BLNKLTHMPLUGTUP
2 months ago - Forbes

Amyris, Inc. (AMRS) Reports Q2 Loss, Misses Revenue Estimates

Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -23.08% and -2.63%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Amyris, Inc. Reports Second Quarter 2021 Financial Results

EMERYVILLE, Calif., Aug. 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brand...

2 months ago - PRNewsWire

AI Identifies Amyris Inc Among Today's Top Shorts

The Dow Jones fell about 163 points, the S&P 500 dipped 0.4%, and the Nasdaq inched up just a bit. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

2 months ago - Forbes